Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.
To be a Butterfly Network shareholder, you need conviction in the company’s ability to commercialize its point-of-care ultrasound technology and shift a growing share of medical imaging workflows onto its digital and AI-powered platforms. The recent five-year, US$15 million upfront licensing agreement with Midjourney offers near-term revenue benefits, but it does not materially address Butterfly’s biggest near-term catalyst, accelerating large enterprise and medical school deals, nor does it mitigate the most pressing risk: persistent delays and slow enterprise sales cycles. Compass AI, recently launched by Butterfly, is likely the announcement most relevant to the Midjourney deal. By showcasing robust, AI-powered workflow enhancements for healthcare institutions, Compass AI may directly influence hospital and enterprise adoption, and is positioned as a catalyst for improved software subscription revenues and higher documentation compliance across client sites. However, investors should also be aware that while new partnerships and product launches may help boost revenue, the challenge of delayed sales cycles and slow enterprise deal-closing remains a real risk...
Read the full narrative on Butterfly Network (it's free!)
Butterfly Network's outlook anticipates $135.9 million in revenue and $17.0 million in earnings by 2028. Achieving this would require a 15.8% annual revenue growth rate and an earnings increase of $79.8 million from current earnings of -$62.8 million.
Uncover how Butterfly Network's forecasts yield a $3.58 fair value, a 16% upside to its current price.
Ten fair value estimates from the Simply Wall St Community range from US$0.87 to US$10.29 per share. While enterprise deal acceleration remains the key catalyst, you may want to compare these varied views alongside your own expectations for sales momentum and revenue growth.
Explore 10 other fair value estimates on Butterfly Network - why the stock might be worth over 3x more than the current price!
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com